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Background/aim: Low-density lipoproteins (LDLs) have been shown to be a major risk factor for coronary artery disease. Multiple
distinct subspecies have been identified among LDL particles on the basis of differences in size, density, and chemical composition.
Particles with a diameter of <25.5 nm are defined as small dense LDL (sdLDL) and have been shown to be associated with increased risk
of coronary disease. Subjects with predominance of sdLDL (pattern B) tend to have higher levels of triglyceride (TG) and lower levels of
high-density lipoprotein cholesterol (HDL-C). In this study, we investigated the distribution of LDL subgroups in subjects with different
types of hyperlipidemia, such as hypertriglyceridemia (hyperTG), hypercholesterolemia (hyperCHO), and combined hyperlipidemia
(HL).
Materials and methods: We used gradient gel electrophoresis and a precipitation method with heparin-magnesium reagent to determine
LDL subgroups.
Results: It was found that there was a significant (P < 0.02) association between the lipid panel and LDL subgroups. The percentage of
sdLDL in all HL groups was higher than in controls, and the ratio of sdLDL was highest in patients with hyperTG.
Conclusion: The predominance of sdLDL is closely related to hyperTG and low HDL-C levels.
Key words: Hyperlipidemia, atherosclerosis, small dense low-density lipoproteins.

1. Introduction
Atherosclerosis is an inflammatory disease characterized
by the accumulation of lipids in arteries, which undergo
gradual thickening, causing decreased elasticity and
reduced blood supply and resulting in constriction of the
lumen. It can lead to ischemia, heart failure, stroke, and
myocardial infarction (1–4). Low-density lipoproteins
(LDLs) are primary plasma lipid carriers in humans that
comprise two distinct subfractions: large buoyant LDL
(lbLDL) and small dense LDL (sdLDL) particles that differ
in size, density, physicochemical composition, metabolic
behavior, and atherogenicity (5).
In studies, the most widely used technique is the
determination of the peak LDL particle diameter by
gradient gel electrophoresis (GGE). Based on the particle
diameter, individuals can be subdivided into those with a
preponderance of dense particles, referred to as pattern
B phenotype, and those with a preponderance of lbLDL
particles, referred to as pattern A phenotype (6).
It has been reported that sdLDLs possess several
proatherogenic properties including greater arterial
wall retention (7), longer half-life in plasma, decreased
* Correspondence: ebru.ezer@deu.edu.tr
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receptor-mediated uptake, increased proteoglycan
binding (8), and susceptibility to oxidation (9,10). LDL
size seems to be an important predictor of cardiovascular
events and predominance of sdLDL has been accepted as
a cardiovascular risk factor by the National Cholesterol
Education Program Adult Treatment Panel III (11).
However, it is still a matter of debate whether to measure
the LDL particle size as a cardiovascular predictor (5).
For this reason, we investigated the distribution of LDL
subgroups in subjects with different kinds of dyslipidemia
[hypertriglyceridemia (hyperTG), hypercholesterolemia
(hyperCHO), and combined hyperlipidemia (HL)]
without considering the reason for dyslipidemia, and we
analyzed its correlation with other lipid parameters. We
used a widely used technique, GGE, to determine LDL
particle diameter, and heparin-magnesium precipitation
to have direct information on the concentration of the
atherogenic sdLDL particles. Furthermore, we compared
the two methods by correlation analysis to find out if the
precipitation method was useful for the quantitation of
sdLDL particles.
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without prior fixation in 0.05% Coomassie R-250 in 50%
methanol and 10% acetic acid, and destained in 20%
methanol and 9% acetic acid (Sigma). For lipid staining
Oil Red O was used and sample lanes were exposed to a
solution comprising 0.1% stain in 60% ethanol at 55–60° C
for 24 h. Then the gels were rehydrated in 5% acetic acid.
To identify LDL subclasses and standard bands in
the lanes, a densitometric scan (ImageMaster Labscan,
Amersham) was performed and the center of the most
prominent band was marked on each lane. Migration
distances were determined, and then the LDL particle
diameter corresponding to each band was calculated from
the slope value of the calibration curve plotted using three
standards of known diameter (thyroglobulin, ferritin, and
silica particles) (Figure 1). After the densitometric analysis
of the gels, LDL subclasses were classified as sdLDL and
lbLDL based on LDL particle size (13), as shown in Figure
2. Type A pattern was characterized by predominance
of lbLDLs with LDL peak diameter of >25.5 nm; type B
pattern was characterized by predominance of sdLDL
particles with LDL particle diameter of ≤25.5 nm.
2.3. Determination of sdLDL cholesterol by simple
precipitation method
sdLDL cholesterol (sdLDL-C) was measured quantitatively
by heparin-magnesium precipitation procedure according
to the method of Hirano et al. (14). Accordingly, the
precipitation reagent (0.1 mL), containing 150 U/mL
heparin-sodium salt and 90 mmol/L MgCl2, was added
to each serum sample (0.1 mL), mixed, and incubated for
10 min at 37 °C. The samples were placed in an ice bath
and allowed to stand for 15 min, and then the precipitate
was collected by centrifuging at 15,000 rpm for 15 min
at 4 °C. An aliquot of the supernatant was removed for
LDL-C analyses. Measured cholesterol content was stated
as sdLDL-C. sdLDL-C% was determined by calculating
the ratio of sdLDL-C to LDL-C in percentages.
2.4. Lipid analysis
Serum TG, TC, HDL-C, and LDL-C concentrations
were determined on an Abbott Architect C-16000 by
commercially available colorimetric kits (Abbott Architect
C-16000 dedicated kits).
Calibration curve

0.7
0.6
Rf (cm)

2. Materials and methods
2.1. Subjects
Subjects were chosen among patients who applied to the
Central Laboratory of Dokuz Eylül University Hospital
for lipid profile analysis. Laboratory results [high density
lipoprotein cholesterol (HDL-C), triglyceride (TG), total
cholesterol (TC), and LDL cholesterol (LDL-C)] were
overviewed and serum samples of patients with different
kinds of dyslipidemia were collected, stored at 4 °C, and
analyzed for LDL subgroups within 3 days. All samples were
obtained after overnight fasting. Patient demographics
were not used because the relationship between the LDL
subgroups and lipid parameters, and not the etiology of
lipid disorder, was the point of interest.
A total of 208 serum samples (96 males and 112
females) were collected and categorized into 4 groups: 1)
the control group (n = 54), which consisted of subjects
with normolipidemia; 2) the hyperTG group (n = 50),
with subjects who had TG of ≥150 mg/dL and TC of <200
mg/dL; 3) the hyperCHO group (n = 52), with subjects
who had TG of <150 mg/dL and TC of ≥200 mg/dL; and
4) the combined HL group (n = 52), with subjects whose
TG and TC values were higher than 150 and 200 mg/dL,
respectively.
2.2. Gradient gel electrophoresis
The particle size of LDLs was determined by 2%–16%
nondenaturing polyacrylamide gel electrophoresis using
commercially available gels (Alamo Gradient Gels, USA).
GGE was performed according to the method of Nichols
and Krauss (12). Briefly, it was carried out at 4 °C using
Tris base (90 mM) and boric acid (80 mM) buffer, pH
8.3, containing 3 mM EDTA and 3 mM sodium acid (all
chemicals from Sigma). The gels were prerun in this buffer
at 125 V for 20 min prior to loading samples and then 15
µL of serum was applied to each lane after diluting 4:1
with 40% sucrose and 0.01% bromophenol blue. Voltage
was adjusted to 15 V for 15 min, then 70 V for 20 min, and
finally 125 V for 24 h.
Calibration was performed with three standards with
known physical properties. One standard was composed
of a protein mixture of thyroglobulin (17 nm), ferritin
(12.2 nm), catalase (10.4 nm), lactate dehydrogenase (8.1
nm), and albumin (7 nm) (HMW Marker Kit, Amersham).
The second standard solution consisted of carboxylatemodified Latex particles (Duke Scientific, 32 nm, used at
1:50 dilution). Since several problems were encountered
in the visualization of Latex particles, a third solution
composed of silica particles (34 nm) bound to fluorescein
isothiocyanate (FITC) was used.
After the electrophoresis, for visualization of the bands,
first the silica was screened fluorometrically at Ex 465/Em
535 nm by using an imaging system (Kodak 2000MM).
Then two lanes containing standard solutions were stained
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Figure 1. Gradient gel calibration line.
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Thyroglobulin

Figure 2. The 2%–16% gel.

2.5. Statistical analysis
Statistical analyses were performed using SPSS version
11.0 for Windows. Variables were normally distributed.
Variables between groups were compared using one-way
ANOVA. Pearson’s single linear regression analysis was
used to assess the correlation between two parameters.
Data are presented as mean ± standard deviation (SD). P ≤
0.05 was considered significant.
3. Results
Plasma lipid profiles of the studied individuals are shown
in the Table. Mean predominant sdLDL diameters
obtained by GGE results are shown in the diameter
column, and quantitative sdLDL-C results obtained by
simple precipitation method are presented in the sdLDL-C
column. lbLDL-C values were calculated by subtracting
sdLDL-C from the total LDL-C value. The control group’s
sdLDL-C level was the lowest among all groups, but the
largest particle diameter was in the hyperCHO group
(Table). The smallest LDL particle diameter was in the
hyperTG group and only this group’s mean LDL diameter
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was the LDL size that was considered as sdLDL (<25.5
nm). TG, TC, HDL-C, and LDL-C levels were not analyzed
statistically, since groups were formed according to these
lipid parameter values. The ANOVA test indicated that
the rate of sdLDL in all HL groups was higher than in the
control group, and the highest rate of sdLDL was in the
hyperTG group.
Linear regression analysis was performed to determine
the possible relationship between LDL particle size
and lipid parameters. A significant negative correlation
between LDL particle diameter and plasma TG (P = 0.01)
(Figure 3) and significant positive correlations between
the particle diameter and TC (P = 0.05) and HDL-C
(P = 0.01) were found. Both sdLDL-C and sdLDL-C%
positively correlated with LDL-C (P = 0.05), TG (P = 0.01),
and TC (P = 0.01) and negatively correlated with HDL-C
(P = 0.01).
When subjects were classified according to their
patterns (pattern A or B) without group separation, only
TG levels were statistically different between the two
patterns (Figure 4).
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Table. Distribution of lipid panel between the groups.
Groups

n

TG
(mg/dL)

TC
(mg/dL)

HDL-C
(mg/dL)

LDL-C
(mg/dL)

sdLDL-C
(mg/dL)

Diameter
(nm)

Group 1
Control

54

92.70 ± 28.58

163.11 ± 29.62

44.98 ± 11.09

88.96 ± 25.80

33.81 ± 12.39¹

25.95 ± 0.79³

Group 2
HyperTG

50

216.84 ± 79.79

170.30 ± 19.79

35.72 ± 7.75

90.22 ± 19.97

39.42 ± 9.02²

25.16 ± 0.72²

Group 3
HyperCHO

52

113.52 ± 29.26

233.06 ± 31.76

52.69 ± 11.50

136.31 ± 32.14

54.50 ± 13.754

26.07 ± 0.824

Group 4
Combined HL

52

222.60 ± 86.89

247.81 ± 34.43

43.27 ± 8.52

145.00 ± 31.20

63.06 ± 14.94

25.74 ± 0.79

Values are mean ± standard deviation. ¹lower than all groups P ≤ 0.05, ²lower than group 3 and 4, ³lower than group 2, 4lower than
group 4.
hyperTG: Hypertriglyceridemia, hyperCHO: hypercholesterolemia, combined HL: combined hyperlipidemia.
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Figure 3. Plots of Pearson’s single linear regression analysis
between LDL particle size and plasma TG levels in 208 subjects.

Figure 4. Comparison of the lipid parameters between two
patterns (A and B).

Lastly, we categorized samples according to sex
and found that only TC and HDL-C were significantly
different between the two groups (P = 0.011 and P = 0.001,
respectively).

properties (6,18,19). Experimental data have suggested
that sdLDL has a greater atherogenic potential when
compared to lbLDL subgroups (5,19–21); for this reason,
it may be appropriate to determine LDL subfractions to
evaluate cardiovascular risk (22). In the present study,
besides LDL-C, LDL subgroups were determined by GGE
according to their particle sizes and their cholesterol
content, and were also measured quantitatively with a
simple precipitation method in different HL groups. The
results were compared with the lipid profile of patients to
show the distribution of LDL subgroups.
Many studies have been conducted to find out whether
it is possible to predict coronary heart disease according
to the distribution of LDL subgroups. Concordantly,
a Quebec cardiovascular study showed that increased
cholesterol levels in the sdLDL subfraction were largely
associated with an increased risk of ischemic heart disease
in men (23).

4. Discussion
The present study shows that the more atherogenic particle,
sdLDL, is found predominantly in hyperlipidemia, in
accordance with previous reports (15–17). The increased rate
of sdLDL is associated with high levels of TG and low levels
of HDL-C in plasma. In this methodology, silica was used as
a standard for GGE for the first time. However, our results
showed that although the heparin-magnesium method was
very useful in evaluating sdLDL-C, it was not reliable enough.
Plasma LDL particles play an important role in the
formation of atherosclerotic lesions. Previous studies
have shown that LDLs comprise a heterogeneous group of
particles that differ in their biological and physicochemical
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In the present study, when the groups were examined
for sdLDL dominance, the highest frequency was in the
hyperTG group. The mean LDL particle diameter of
this group was the smallest, and only this group had a
particle diameter that corresponded to sdLDL. There was
also a negative correlation between TG and LDL particle
diameter, and TG levels had a positive correlation with
sdLDL-C and sdLDL-C%. The latest studies searching for
the best marker for reducing the risk of atherosclerotic
cardiovascular diseases remarked on the importance of
LDL particle size (24). All these results strengthen the
conclusion that increased TG concentration causes high
levels of atherogenic sdLDL in plasma. Although hyperTG
by itself as an atherogenic risk factor is still controversial,
its consequences, such as TG rich remnants, and its
association with apoC-III and a higher number of sdLDL
particles are considered atherogenic (25,26). Our results
also demonstrated significant negative correlation between
TG and HDL-C. Similar results were obtained by Griffin
et al. and Rizzo et al. (27–29). Austin et al. (30) found
that pattern B was associated with a 2-fold increment in
plasma TG, higher plasma apoB, and intermediate density
lipoproteins levels as well as reduced HDL-C and apoA-I
concentration. Campos et al. (31) reported a highly
significant correlation between LDL size and plasma TG
levels. Plasma LDL subtype distribution has also been
studied in Turkish people with coronary stenosis, and Er
Öztaş et al. (32) found that patients with sdLDL positivity
had significantly higher levels of TG.
When all cases were classified as either pattern A
or pattern B, TG and HDL-C levels were significantly
different between the two groups, but there were no
differences in their TC and LDL-C levels. In the pattern B
group, TG was higher and HDL-C levels were lower than
in the pattern A group. These results indicated a typical
atherogenic dyslipidemia phenotype and confirmed the
relationship between sdLDL and TG concentration once
again. Similarly, Maruyama et al. reported similar TC and
LDL-C values between LDL subgroups, but they suggested
a combined parameter, the TG/HDL-C ratio, as a more
beneficial parameter to assess the presence of sdLDL (33).
They determined that TC and LDL-C values were not
significantly different between LDL subgroups. Another
study showed that in renal transplant recipients, despite
LDL-C values that were similar with those of the controls,
sdLDL-C was higher, and this patient group had impaired
distribution of LDL particles (13).
One of the methods preferred for analysis of LDL
and HDL subgroups is GGE. It is a reliable method and
presents good accuracy with low sample consumption. In
this method, mostly Latex beads are used as a reference
marker, but we encountered some problems in the
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application and visualization of this material. They
either did not enter the gel or failed to focus on the gel.
Instead, we used FITC-labeled silica particles, which have
a similar particle diameter to the Latex beads. Except for
the difficulty of working in the dark from the beginning to
the end of the experiment (since the material is florescent),
silica particles were stable and easy to load and visualize.
Skoglund-Andersson et al. reported the same problem
with the Latex particles, and they suggested isolated the
Lp(a) fraction as a reference protein, even though it had
difficulties with stability and standardization (34). We
did not find any other application of silica particles in
the application of GGE in our literature review, so this is
probably the first time silica particles have been used for
analysis for this purpose.
GGE is considered convenient to use to determine
LDL subgroups, and previous studies have shown that
the results of electrophoretic separation were very similar
between isolated LDL and serum samples (35). Although
it is regarded as a ‘gold standard’ for identifying sdLDL
particles (36), it does not provide direct information
concerning the concentration of the atherogenic sdLDL
particles. Therefore, we used another method, heparinmagnesium precipitation, to determine the concentration of
the atherogenic sdLDL particles. This simple precipitation
method has a short assay time, a large number of serum
samples can be separated in the same run, and the required
equipment is found very easily. Hirano et al. studied their
method in patients with different lipid phenotypes and
confirmed the accuracy of their method by comparing
it with GGE and suggested it for use in routine analysis
(14,22,37,38). We compared Hirano’s method with GGE
by correlation analysis to verify the heparin-magnesium
method, but we did not get similar results with the GGE
and precipitation methods. In particular, an increased
level of sdLDL, found especially in the hyperTG group by
GGE, could not be shown by Hirano’s method. Our mean
sdLDL-C levels (control: 33.8 mg/dL, hyperTG: 39.42
mg/dL, combined HL: 63.1 mg/dL) were close to those of
another study (control: 30 mg/dL, hyperTG: 41 mg/dL,
combined HL: 62 mg/dL) (39) that used the same method,
and that study also stated that sdLDL-C levels in hyperTG
and combined HL samples were higher in the Hirano et
al. study than in their results. During the application of
the method we also noticed that, after precipitation of the
samples, in some samples the supernatant was not clear
enough. Hirano et al. mentioned in a review (40) the
need to modify the protocol by using a filter in hyperTG
serum to overcome this turbidity. Therefore, although the
precipitation method yields quantitative results and is easy
to perform, GGE should be preferred in order to obtain
more reliable results in studies related to LDL subclasses.
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Although studies have shown that genetic and
environmental changes affected the distribution of LDL
subgroups (19), we could not find any differences between
women and men.

A potential limitation of this study was the deficiency
of patient demographics. This meant we could not establish
a connection with clinical aspects of LDL phenotype.
In conclusion, a high predominance of sdLDL is closely
related to hyperTG and low HDL-C levels.
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